Search

Author/Creator Hellmann, Matthew D

1. A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers. (28th November 2018)

Authors:
Sabari, Joshua K; Offin, Michael; Stephens, Dennis; Ni, Andy; Lee, Adrian; Pavlakis, Nick; Clarke, Stephen; Diakos, Connie I; Datta, Sutirtha; Tandon, Nidhi; Martinez, Andres; Myers, Mackenzie L; Makhnin, Alex; Leger, Ysleni; Yu, Helena A; Paik, Paul K; Chaft, Jamie E; Kris, Mark G; Jeon, Jeong O...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 111:Number 6(2019)
Page Start:
575
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer. Issue 2 (13th September 2020)

Authors:
Reuss, Joshua E; Anagnostou, Valsamo; Cottrell, Tricia R; Smith, Kellie N; Verde, Franco; Zahurak, Marianna; Lanis, Mara; Murray, Joseph C; Chan, Hok Yee; McCarthy, Caroline; Wang, Daphne; White, James R; Yang, Stephen; Battafarano, Richard; Broderick, Stephen; Bush, Errol; Brock, Malcolm; Ha, Ji...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Issue 1 (January 2017)

Authors:
Hellmann, Matthew D; Rizvi, Naiyer A; Goldman, Jonathan W; Gettinger, Scott N; Borghaei, Hossein; Brahmer, Julie R; Ready, Neal E; Gerber, David E; Chow, Laura Q; Juergens, Rosalyn A; Shepherd, Frances A; Laurie, Scott A; Geese, William J; Agrawal, Shruti; Young, Tina C; Li, Xuemei; Antonia, Scott J
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Page Start:
31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study. Issue 4 (April 2019)

Authors:
Leighl, Natasha B; Hellmann, Matthew D; Hui, Rina; Carcereny, Enric; Felip, Enriqueta; Ahn, Myung-Ju; Eder, Joseph Paul; Balmanoukian, Ani S; Aggarwal, Charu; Horn, Leora; Patnaik, Amita; Gubens, Matthew; Ramalingam, Suresh S; Lubiniecki, Gregory M; Zhang, Jin; Piperdi, Bilal; Garon, Edward B
Journal:
Lancet
Issue:
Volume 7:Issue 4(2019)
Page Start:
347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer. Issue 6 (1st June 2022)

Authors:
Lopez de Rodas, Miguel; Nagineni, Venkata; Ravi, Arvind; Datar, Ila J; Mino-Kenudson, Mari; Corredor, German; Barrera, Cristian; Behlman, Lindsey; Rimm, David L; Herbst, Roy S; Madabhushi, Anant; Riess, Jonathan W; Velcheti, Vamsidhar; Hellmann, Matthew D; Gainor, Justin; Schalper, Kurt A
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma. Issue 5 (31st May 2022)

Authors:
Govindan, Ramaswamy; Aggarwal, Charu; Antonia, Scott J; Davies, Marianne; Dubinett, Steven M; Ferris, Andrea; Forde, Patrick M; Garon, Edward B; Goldberg, Sarah B; Hassan, Raffit; Hellmann, Matthew D; Hirsch, Fred R; Johnson, Melissa L; Malik, Shakun; Morgensztern, Daniel; Neal, Joel W; Patel, Jy...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 5(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy. Issue 3 (14th March 2023)

Authors:
Rizvi, Naiyer; Ademuyiwa, Foluso O; Cao, Z Alexander; Chen, Helen X; Ferris, Robert L; Goldberg, Sarah B; Hellmann, Matthew D; Mehra, Ranee; Rhee, Ina; Park, Jong Chul; Kluger, Harriet; Tawbi, Hussein; Sullivan, Ryan J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade. Issue 2 (10th February 2021)

Authors:
Beattie, Jason; Rizvi, Hira; Fuentes, Paige; Luo, Jia; Schoenfeld, Adam; Lin, I-Hsin; Postow, Michael; Callahan, Margaret; Voss, Martin H; Shah, Neil J; Betof Warner, Allison; Chawla, Mohit; Hellmann, Matthew D
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗